獣医炭疽症ワクチンの世界市場インサイト・予測(~2025年)

【英語タイトル】Global Veterinary Anthrax Vaccines Market Insights, Forecast to 2025

QYResearchが出版した調査資料(QYR20FB12298)・商品コード:QYR20FB12298
・発行会社(調査会社):QYResearch
・発行日:2019年12月(※2024年版があります。お問い合わせください)
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、世界の獣医炭疽症ワクチン市場について調査・分析し、以下の構成でお届け致します。獣医炭疽症ワクチンの種類別には、無細胞PAワクチン、生ワクチンに、用途別には、牛、羊、豚、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別獣医炭疽症ワクチン売上データ
・地域別獣医炭疽症ワクチン市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別獣医炭疽症ワクチン市場規模:無細胞PAワクチン、生ワクチン
・用途別獣医炭疽症ワクチン市場規模:牛、羊、豚、その他
・主要メーカーの企業情報:Agrovet、Bayer Sanidad Animal、Biogenesis Bago SA、Botswana Vaccine Institute、Central Veterinary Control and Research Institute、Centro Diagnostico Veterinario、Ceva Sante Animale、Colorado Serum Company、Empresa Colombiana de Productos Veterinarios S.A、Indian Immunologicals Limited、Institute for Biological Products、Intervac (PVT) Ltd、JOVAC
・獣医炭疽症ワクチンの市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...
【レポートの概要】

The global Veterinary Anthrax Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Veterinary Anthrax Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Veterinary Anthrax Vaccines in key regions like North America, Europe, China and Japan, focuses on the consumption of Veterinary Anthrax Vaccines in these regions.
This research report categorizes the global Veterinary Anthrax Vaccines market by top players/brands, region, type and end user. This report also studies the global Veterinary Anthrax Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Agrovet
Bayer Sanidad Animal
Biogenesis Bago SA
Botswana Vaccine Institute
Central Veterinary Control and Research Institute
Centro Diagnostico Veterinario
Ceva Sante Animale
Colorado Serum Company
Empresa Colombiana de Productos Veterinarios S.A
Indian Immunologicals Limited
Institute for Biological Products
Intervac (PVT) Ltd
JOVAC

Veterinary Anthrax Vaccines market size by Type
Cell Free PA Vaccines
Live Vaccines

Veterinary Anthrax Vaccines market size by Applications
Cow
Sheep
Swine
Other

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Veterinary Anthrax Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Veterinary Anthrax Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Veterinary Anthrax Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Veterinary Anthrax Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Veterinary Anthrax Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Veterinary Anthrax Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Study Coverage
1.1 Veterinary Anthrax Vaccines Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Veterinary Anthrax Vaccines Market Size Growth Rate by Type
1.4.2 Cell Free PA Vaccines
1.4.3 Live Vaccines
1.5 Market by Application
1.5.1 Global Veterinary Anthrax Vaccines Market Size Growth Rate by Application
1.5.2 Cow
1.5.3 Sheep
1.5.4 Swine
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Veterinary Anthrax Vaccines Market Size
2.1.1 Global Veterinary Anthrax Vaccines Revenue 2014-2025
2.1.2 Global Veterinary Anthrax Vaccines Sales 2014-2025
2.2 Veterinary Anthrax Vaccines Growth Rate by Regions
2.2.1 Global Veterinary Anthrax Vaccines Sales by Regions
2.2.2 Global Veterinary Anthrax Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Veterinary Anthrax Vaccines Sales by Manufacturers
3.1.1 Veterinary Anthrax Vaccines Sales by Manufacturers
3.1.2 Veterinary Anthrax Vaccines Sales Market Share by Manufacturers
3.2 Veterinary Anthrax Vaccines Revenue by Manufacturers
3.2.1 Veterinary Anthrax Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Veterinary Anthrax Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Veterinary Anthrax Vaccines Price by Manufacturers
3.4 Veterinary Anthrax Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Veterinary Anthrax Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary Anthrax Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Veterinary Anthrax Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Veterinary Anthrax Vaccines Sales by Type
4.2 Global Veterinary Anthrax Vaccines Revenue by Type
4.3 Veterinary Anthrax Vaccines Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Veterinary Anthrax Vaccines Breakdown Data by Application

6 North America
6.1 North America Veterinary Anthrax Vaccines by Country
6.1.1 North America Veterinary Anthrax Vaccines Sales by Country
6.1.2 North America Veterinary Anthrax Vaccines Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Veterinary Anthrax Vaccines by Type
6.3 North America Veterinary Anthrax Vaccines by Application

7 Europe
7.1 Europe Veterinary Anthrax Vaccines by Country
7.1.1 Europe Veterinary Anthrax Vaccines Sales by Country
7.1.2 Europe Veterinary Anthrax Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Veterinary Anthrax Vaccines by Type
7.3 Europe Veterinary Anthrax Vaccines by Application

8 Asia Pacific
8.1 Asia Pacific Veterinary Anthrax Vaccines by Region
8.1.1 Asia Pacific Veterinary Anthrax Vaccines Sales by Region
8.1.2 Asia Pacific Veterinary Anthrax Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Veterinary Anthrax Vaccines by Type
8.3 Asia Pacific Veterinary Anthrax Vaccines by Application

9 Central & South America
9.1 Central & South America Veterinary Anthrax Vaccines by Country
9.1.1 Central & South America Veterinary Anthrax Vaccines Sales by Country
9.1.2 Central & South America Veterinary Anthrax Vaccines Revenue by Country
9.1.3 Brazil
9.2 Central & South America Veterinary Anthrax Vaccines by Type
9.3 Central & South America Veterinary Anthrax Vaccines by Application

10 Middle East and Africa
10.1 Middle East and Africa Veterinary Anthrax Vaccines by Country
10.1.1 Middle East and Africa Veterinary Anthrax Vaccines Sales by Country
10.1.2 Middle East and Africa Veterinary Anthrax Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Veterinary Anthrax Vaccines by Type
10.3 Middle East and Africa Veterinary Anthrax Vaccines by Application

11 Company Profiles
11.1 Agrovet
11.1.1 Agrovet Company Details
11.1.2 Company Business Overview
11.1.3 Agrovet Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Agrovet Veterinary Anthrax Vaccines Products Offered
11.1.5 Agrovet Recent Development
11.2 Bayer Sanidad Animal
11.2.1 Bayer Sanidad Animal Company Details
11.2.2 Company Business Overview
11.2.3 Bayer Sanidad Animal Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bayer Sanidad Animal Veterinary Anthrax Vaccines Products Offered
11.2.5 Bayer Sanidad Animal Recent Development
11.3 Biogenesis Bago SA
11.3.1 Biogenesis Bago SA Company Details
11.3.2 Company Business Overview
11.3.3 Biogenesis Bago SA Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Biogenesis Bago SA Veterinary Anthrax Vaccines Products Offered
11.3.5 Biogenesis Bago SA Recent Development
11.4 Botswana Vaccine Institute
11.4.1 Botswana Vaccine Institute Company Details
11.4.2 Company Business Overview
11.4.3 Botswana Vaccine Institute Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Botswana Vaccine Institute Veterinary Anthrax Vaccines Products Offered
11.4.5 Botswana Vaccine Institute Recent Development
11.5 Central Veterinary Control and Research Institute
11.5.1 Central Veterinary Control and Research Institute Company Details
11.5.2 Company Business Overview
11.5.3 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Products Offered
11.5.5 Central Veterinary Control and Research Institute Recent Development
11.6 Centro Diagnostico Veterinario
11.6.1 Centro Diagnostico Veterinario Company Details
11.6.2 Company Business Overview
11.6.3 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Products Offered
11.6.5 Centro Diagnostico Veterinario Recent Development
11.7 Ceva Sante Animale
11.7.1 Ceva Sante Animale Company Details
11.7.2 Company Business Overview
11.7.3 Ceva Sante Animale Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Ceva Sante Animale Veterinary Anthrax Vaccines Products Offered
11.7.5 Ceva Sante Animale Recent Development
11.8 Colorado Serum Company
11.8.1 Colorado Serum Company Company Details
11.8.2 Company Business Overview
11.8.3 Colorado Serum Company Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Colorado Serum Company Veterinary Anthrax Vaccines Products Offered
11.8.5 Colorado Serum Company Recent Development
11.9 Empresa Colombiana de Productos Veterinarios S.A
11.9.1 Empresa Colombiana de Productos Veterinarios S.A Company Details
11.9.2 Company Business Overview
11.9.3 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Products Offered
11.9.5 Empresa Colombiana de Productos Veterinarios S.A Recent Development
11.10 Indian Immunologicals Limited
11.10.1 Indian Immunologicals Limited Company Details
11.10.2 Company Business Overview
11.10.3 Indian Immunologicals Limited Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Indian Immunologicals Limited Veterinary Anthrax Vaccines Products Offered
11.10.5 Indian Immunologicals Limited Recent Development
11.11 Institute for Biological Products
11.12 Intervac (PVT) Ltd
11.13 JOVAC

12 Future Forecast
12.1 Veterinary Anthrax Vaccines Market Forecast by Regions
12.1.1 Global Veterinary Anthrax Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Veterinary Anthrax Vaccines Revenue Forecast by Regions 2019-2025
12.2 Veterinary Anthrax Vaccines Market Forecast by Type
12.2.1 Global Veterinary Anthrax Vaccines Sales Forecast by Type 2019-2025
12.2.2 Global Veterinary Anthrax Vaccines Revenue Forecast by Type 2019-2025
12.3 Veterinary Anthrax Vaccines Market Forecast by Application
12.4 North America Veterinary Anthrax Vaccines Forecast
12.5 Europe Veterinary Anthrax Vaccines Forecast
12.6 Asia Pacific Veterinary Anthrax Vaccines Forecast
12.7 Central & South America Veterinary Anthrax Vaccines Forecast
12.8 Middle East and Africa Veterinary Anthrax Vaccines Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Veterinary Anthrax Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



【掲載企業】

Agrovet、Bayer Sanidad Animal、Biogenesis Bago SA、Botswana Vaccine Institute、Central Veterinary Control and Research Institute、Centro Diagnostico Veterinario、Ceva Sante Animale、Colorado Serum Company、Empresa Colombiana de Productos Veterinarios S.A、Indian Immunologicals Limited、Institute for Biological Products、Intervac (PVT) Ltd、JOVAC

★調査レポート[獣医炭疽症ワクチンの世界市場インサイト・予測(~2025年)] (コード:QYR20FB12298)販売に関する免責事項を必ずご確認ください。
★調査レポート[獣医炭疽症ワクチンの世界市場インサイト・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆